glipizide has been researched along with Cancer of Prostate in 1 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, C | 1 |
| Yang, Y | 2 |
| Li, J | 2 |
| Zhou, Q | 1 |
| Wen, Y | 1 |
| Zeng, C | 1 |
| Zheng, L | 1 |
| Zhang, Q | 1 |
| He, X | 1 |
| Zhou, J | 1 |
| Shao, C | 1 |
| Wang, L | 1 |
1 other study available for glipizide and Cancer of Prostate
| Article | Year |
|---|---|
Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antigens, Polyomavirus Transforming; Cell Line, Tumor; Cell Prolif | 2016 |